About Deborah Waterhouse
Deborah Waterhouse was appointed to the GSK Leadership Team on 8 January 2020. She became Chief Executive Officer of ViiV Healthcare on 1 April 2017. ViiV Healthcare is majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders.